- Home
- INBX vs SANG Comparison
INBX vs SANG Comparison
Compare INBX & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- SANG
- Stock Information
- Founded
- INBX 2010
- SANG 1984
- Country
- INBX United States
- SANG Canada
- Employees
- INBX N/A
- SANG N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- INBX Health Care
- SANG Technology
- Exchange
- INBX Nasdaq
- SANG Nasdaq
- Market Cap
- INBX 218.9M
- SANG 247.2M
- IPO Year
- INBX 2020
- SANG 2021
- Fundamental
- Price
- INBX $14.19
- SANG $7.80
- Analyst Decision
- INBX Hold
- SANG
- Analyst Count
- INBX 1
- SANG 0
- Target Price
- INBX N/A
- SANG N/A
- AVG Volume (30 Days)
- INBX 80.6K
- SANG 9.1K
- Earning Date
- INBX 11-14-2024
- SANG 02-06-2025
- Dividend Yield
- INBX N/A
- SANG N/A
- EPS Growth
- INBX N/A
- SANG N/A
- EPS
- INBX 119.38
- SANG N/A
- Revenue
- INBX $1,568,000.00
- SANG $244,406,000.00
- Revenue This Year
- INBX N/A
- SANG $3.36
- Revenue Next Year
- INBX N/A
- SANG $7.39
- P/E Ratio
- INBX $0.11
- SANG N/A
- Revenue Growth
- INBX 19.24
- SANG N/A
- 52 Week Low
- INBX $10.80
- SANG $2.50
- 52 Week High
- INBX $18.95
- SANG $7.84
- Technical
- Relative Strength Index (RSI)
- INBX 47.10
- SANG 73.82
- Support Level
- INBX $12.51
- SANG $6.97
- Resistance Level
- INBX $14.86
- SANG $7.65
- Average True Range (ATR)
- INBX 1.05
- SANG 0.26
- MACD
- INBX -0.14
- SANG 0.04
- Stochastic Oscillator
- INBX 38.89
- SANG 96.13
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.